Epidermal growth factor receptor inhibitor in advanced basal cell carcinoma

Amir Amirabadi; Amirhosein Alami; Hamid Ahanchian; Nazila Ariaee; Nasrin Moazzen

doi:10.1002/ccr3.4021

Clinical Case Reports (May 2021)

Epidermal growth factor receptor inhibitor in advanced basal cell carcinoma

Amir Amirabadi,
Amirhosein Alami,
Hamid Ahanchian,
Nazila Ariaee,
Nasrin Moazzen

Affiliations

Amir Amirabadi: Department of Internal Medicine Azad University of Medical Sciences Mashhad Iran
Amirhosein Alami: Department of Biology Azad University of Medical Sciences Mashhad Iran
Hamid Ahanchian: Clinical Research Development Unit of Akbar hospital Mashhad University of medical Sciences Mashhad Iran
Nazila Ariaee: Clinical Research Development Unit of Akbar hospital Mashhad University of medical Sciences Mashhad Iran
Nasrin Moazzen: Clinical Research Development Unit of Akbar hospital Mashhad University of medical Sciences Mashhad Iran

DOI: https://doi.org/10.1002/ccr3.4021
Journal volume & issue: Vol. 9, no. 5
pp. n/a – n/a

Abstract

Read online

Abstract Cetuximab can be used for the treatment of advanced basal cell carcinoma, especially when the patient cannot tolerate routine chemotherapy. Future studies are needed to confirm it.

Published in Clinical Case Reports

ISSN: 2050-0904 (Online)
Publisher: Wiley
Country of publisher: United Kingdom
LCC subjects: Medicine: Medicine (General)
Website: http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)2050-0904

About the journal

Abstract

Keywords